La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Neostriatum (drug effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neostriatum (diagnostic imaging) < Neostriatum (drug effects) < Neostriatum (enzymology)  Facettes :

List of bibliographic references indexed by Neostriatum (drug effects)

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
001698 (2011) Jacqueline A. Gleave [Canada] ; Troy H. Farncombe ; Chantal Saab ; Laurie C. DoeringCorrelative single photon emission computed tomography imaging of [123I]altropane binding in the rat model of Parkinson's.
001997 (2010) Roberto Cilia [Canada] ; Ji Hyun Ko ; Sang Soo Cho ; Thilo Van Eimeren ; Giorgio Marotta ; Giovanna Pellecchia ; Gianni Pezzoli ; Angelo Antonini ; Antonio P. StrafellaReduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling.
001B26 (2010) I. Irrcher ; H. Aleyasin ; E. L. Seifert ; S. J. Hewitt ; S. Chhabra ; M. Phillips ; A. K. Lutz ; M. W. C. Rousseaux ; L. Bevilacqua ; A. Jahani-Asl ; S. Callaghan ; J. G. Maclaurin ; K. F. Winklhofer ; P. Rizzu ; P. Rippstein ; R. H. Kim ; C. X. Chen [Canada] ; E. A. Fon [Canada] ; R. S. Slack ; M. E. Harper ; H. M. Mcbride ; T. W. Mak ; D. S. Park [Corée du Sud, Canada]Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics
001E76 (2009) Dirk W. Luchtman [Canada] ; Di Shao ; Cai SongBehavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease.
002449 (2007) B. Rajakumar [Canada] ; B A Flumerfelt ; A W Hrycyshyn ; N. RajakumarNitric oxide-containing neurons in long-term grafts in a rat model of Parkinson's disease.
002915 (2006) Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Catherine C. Tenn [Canada] ; Lennard P. Niles [Canada]Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease
003F76 (1995) Céline Gagnon [Canada] ; Baltazar Gomez-Mancilla [Canada] ; Rudolf Markstein [Suisse] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Effect of adding the D-1 agonist CY 208–243 to chronic bromocriptine treatment of MPTP-monkeys: Regional changes of brain dopamine receptors
004459 (1993) C. Gagnon [Canada] ; B. Gomez-Mancilla ; P. J. Bedard ; T. Di Paolo [Canada]Chronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Neostriatum (drug effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Neostriatum (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Neostriatum (drug effects)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022